The Latest
-
Toshe_O via Getty Images
Rise in VC activity tees up ‘strong year’ for medtech funding: PitchBook
Improvements in VC funding contrasted with M&A activity, which has fallen short of the level PitchBook predicted under the Trump administration.
-
Courtesy of Dexcom
Dexcom recalls more than 2 million CGM receivers for lack of audible alarm
Severe adverse events, including seizure and loss of consciousness, were potentially linked to the issue, based on 56 reports Dexcom received.
-
Courtesy of Medtronic
Medtronic training pact includes Hugo robot, cardiac ablation tech
The medical device maker is partnering with IRCAD, a surgical education and research institute, to train medical personnel in cardiovascular, neuroscience and minimally invasive specialties.
-
Stock via Getty Images
Q’Apel recalls clot removal device in response to FDA warning letter
Rather than pursuing a new regulatory pathway, Q'Apel said it is discontinuing the recalled system “as part of its strategic shift toward newer technologies.”
-
gorodenkoff via Getty Images
Could the FDA take an indirect approach to regulate LDTs?
Attorneys said many questions remain about LDT regulation after the FDA lost its legal fight. A recent warning letter could be a clue to future enforcement.
-
Brad Barket via Getty Images
Anne Wojcicki wins bid to buy back 23andMe for $305M
A nonprofit led by the co-founder and former CEO of 23andMe outbid competitors for nearly all of the company’s assets.
